Mirae Asset Global Etfs Holdings »

Relmada Therapeutics shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $300k 43k 6.92

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Apple (AAPL)
Cameco Corporation (CCJ)
Global X Fds Russell 2000 Etf (RSSL)
Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Wheaton Precious Metals Corp (WPM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Relmada Therapeutics

Jupiter Topco
Henderson Group
BlackRock
Squadron Capital Management
VR Adviser
Spruce Street Capital
Adage Capital Partners GP
Vanguard Capital Management
Jones Hill Capital
OrbiMed Advisors
Geode Capital Management
Millennium Management
Marshall Wace
Ikarian Capital
Driehaus Capital Management

View all funds holding Relmada Therapeutics